The researchers called the system a “promising prototype,” while cautioning that further validation is needed.
Micro Cap Daily | Microcap and small cap company nTwo judges in a Federal Circuit panel on Tuesday seemed unpersuaded by an argument from Roche unit Genentech Inc. that a Delaware federal judge wrongly let Sandoz Inc. off the hook for infringing patents on the pulmonary fibrosis drug Esbriet.
Micro Cap Daily | Microcap and small cap company nLargely funded by government grants for the better part of its first decade, a UC Berkeley spinout has secured a new CEO and the funds to take its research into the clinic in early 2024. The biotech, named by one of the co-founder’s daughters and originally scrapped together with NIH
Micro Cap Daily | Microcap and small cap company nSummary This reports provides a data-driven overview of the current and future competitive landscape in Urticaria therapeutics. SynopsisNew York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report “Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials…
TUESDAY, Oct. 4, 2022 (HealthDay News) -- The incidence rates of breast cancer have increased slowly and breast cancer mortality rates have declined in recent years, with a persistent racial
Researchers honoured for game-changing methods to neatly couple molecules, including reactions that can be run in living cells.
Micro Cap Daily | Microcap and small cap company nClyde A. Smith, Jr., 84, passed away on Tuesday, September 27th, 2022 surrounded by his family.
Micro Cap Daily | Microcap and small cap company nAnew Medical, Inc (OTCMKTS: LEAS) is up big after the Company announced it has acquired five market-approved anti-cancer drugs approved for sale in Germany. The Market Authorizations (MA’s) are for four of the drugs that comprise the “FOLFOX” and “FOLFIRI” multi-drug regimens used in treatment of me…
Micro Cap Daily | Microcap and small cap company nCARLSBAD, Calif.--(BUSINESS WIRE)--Oct 3, 2022--
Basel, 3 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Matt Sause (45), currently Head of Roche Diagnostics’ North America Region, will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023. Thomas Schinecker, the incumbent C…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023](https://s.yimg.com/uu/api/res/1.2/gJB9QlKEemvUDvTucA5Zaw--~B/aD0xOTg7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globe_newswire_uk_374/d295bae68c32358ba6ac888e76c1cca2)
Financial Disclosure I have the following financial interests or relationships to disclose: ... | October 3, 2022
Moderna is joining Pfizer in promoting updated Covid-19 vaccines for the fall in a TV campaign. Moderna’s effort is relatively smaller compared to Pfizer’s pharma-leading spending on NFL football games. However, the new Moderna campaign has a similar core message around “updated” boosters. The short…
PharmTechSAN FRANCISCO (KRON) — Students in the College of Science and Engineering (CoSE) at San Francisco State University can expect a new home for their classes fairly soon. The university is curre…
PharmTechResearchers sought to determine whether camidanlumab tesirine would be effective in patients with relapsed/refractory classical Hodgkin lymphoma.
PharmTechThe 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.
During a debate a the SOHO 2022 Annual Meeting, Jennifer R Brown, MD, PhD presented in favor of combining small molecules in CLL. Making the argument for sequencing small molecules in CLL was Anthony Mato, MD.
Vegzelma became the fourth biosimilar referencing Avastin (bevacizumab) to be approved for use in the United States for several types of cancer.
Financial Disclosure I have the following financial interests or relationships to disclose: ... | October 1, 2022
“Everyone swims for a different reason: Some people are swimming in honor of somebody who’s beat cancer, some people swim in memory of someone who’s passed away from cancer.”…
The Mercury NewsAdaptive fashion is at the nexus of economics, representation, and a new possibility for brand growth. The industry has to see it as as offering that will have a significant ripple effect moving fashion beyond aesthetics, toward generating a real social value.
Forbes
